Current concepts in mild cognitive impairment
- PMID: 11735772
- DOI: 10.1001/archneur.58.12.1985
Current concepts in mild cognitive impairment
Abstract
The field of aging and dementia is focusing on the characterization of the earliest stages of cognitive impairment. Recent research has identified a transitional state between the cognitive changes of normal aging and Alzheimer's disease (AD), known as mild cognitive impairment (MCI). Mild cognitive impairment refers to the clinical condition between normal aging and AD in which persons experience memory loss to a greater extent than one would expect for age, yet they do not meet currently accepted criteria for clinically probable AD. When these persons are observed longitudinally, they progress to clinically probable AD at a considerably accelerated rate compared with healthy age-matched individuals. Consequently, this condition has been recognized as suitable for possible therapeutic intervention, and several multicenter international treatment trials are under way. Because this is a topic of intense interest, a group of experts on aging and MCI from around the world in the fields of neurology, psychiatry, geriatrics, neuropsychology, neuroimaging, neuropathology, clinical trials, and ethics was convened to summarize the current state of the field of MCI. Participants reviewed the world scientific literature on aging and MCI and summarized the various topics with respect to available evidence on MCI. Diagnostic criteria and clinical outcomes of these subjects are available in the literature. Mild cognitive impairment is believed to be a high-risk condition for the development of clinically probable AD. Heterogeneity in the use of the term was recognized, and subclassifications were suggested. While no treatments are recommended for MCI currently, clinical trials regarding potential therapies are under way. Recommendations concerning ethical issues in the diagnosis and the management of subjects with MCI were made.
Similar articles
-
[Neuropsychological impairment in the early Alzheimer's disease].Encephale. 2007 May-Jun;33(3 Pt 1):310-6. doi: 10.1016/s0013-7006(07)92044-8. Encephale. 2007. PMID: 17675928 Review. French.
-
Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease.Acta Neurol Scand Suppl. 2003;179:34-41. Acta Neurol Scand Suppl. 2003. PMID: 12603249 Review.
-
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials.Arch Neurol. 2004 Jan;61(1):59-66. doi: 10.1001/archneur.61.1.59. Arch Neurol. 2004. PMID: 14732621 Clinical Trial.
-
The neuropathology of probable Alzheimer disease and mild cognitive impairment.Ann Neurol. 2009 Aug;66(2):200-8. doi: 10.1002/ana.21706. Ann Neurol. 2009. PMID: 19743450 Free PMC article.
-
Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.Clin Ther. 2006 Jul;28(7):991-1001. doi: 10.1016/j.clinthera.2006.07.006. Clin Ther. 2006. PMID: 16990077 Review.
Cited by
-
Quality of life in persons with mild cognitive impairment: a systematic review and meta-analysis.Dement Neuropsychol. 2024 Aug 26;18:e20230093. doi: 10.1590/1980-5764-DN-2023-0093. eCollection 2024. Dement Neuropsychol. 2024. PMID: 39193465 Free PMC article. Review.
-
Neurocognitive Features of Mild Cognitive Impairment and Distress Symptoms in Older Adults Without Major Depression.Clin Interv Aging. 2024 Aug 21;19:1445-1459. doi: 10.2147/CIA.S473730. eCollection 2024. Clin Interv Aging. 2024. PMID: 39185278 Free PMC article.
-
Detection of neurophysiological markers of cognitive reserve: an EEG study.Front Aging Neurosci. 2024 Aug 7;16:1401818. doi: 10.3389/fnagi.2024.1401818. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39170899 Free PMC article.
-
Correlation of brain tissue volume loss with inflammatory biomarkers IL1β, P-tau, T-tau, and NLPR3 in the aging cognitively impaired population.Front Aging Neurosci. 2024 Jul 23;16:1388654. doi: 10.3389/fnagi.2024.1388654. eCollection 2024. Front Aging Neurosci. 2024. PMID: 39109268 Free PMC article.
-
Transcranial Electrical Stimulation: Clinical Implication and Practice for Treatment of Psychiatric Illness.Clin Psychopharmacol Neurosci. 2024 Aug 31;22(3):391-404. doi: 10.9758/cpn.23.1118. Epub 2023 Sep 11. Clin Psychopharmacol Neurosci. 2024. PMID: 39069679 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources